Mathieu Gerfaud-Valentin
Overview
Explore the profile of Mathieu Gerfaud-Valentin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagle S, Nguyen Y, Guerry M, Quemeneur T, Titeca-Beauport D, Crepin T, et al.
Ann Rheum Dis
. 2025 Feb;
84(2):319-328.
PMID: 39919904
Background: The PEXIVAS (Plasma exchange and glucocorticoids in severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis) trial showed that a reduced-dose glucocorticoid regimen (redGC) was non-inferior to a standard-dose regimen (standGC) with...
2.
Cottu A, Guillet S, Viallard J, Riviere E, Cheze S, Gobert D, et al.
Blood
. 2024 Oct;
145(2):244-247.
PMID: 39476101
In an open prospective, multicenter study enrolling 48 selected patients with chronic immune thrombocytopenia who achieved complete response for 1 year on thrombopoietin receptor agonists, half of the patients maintained...
3.
Theuriet J, Gerfaud-Valentin M, Durel C, Gouya L, Pegat A
J Peripher Nerv Syst
. 2024 Oct;
29(4):567-569.
PMID: 39425488
Background And Aims: Porphyrias are inherited metabolic disorders caused by mutations in genes encoding enzymes involved in the heme biosynthetic pathway, leading to the accumulation of heme precursors. Acute hepatic...
4.
Lequain H, Streichenberger N, Gallay L, Gerfaud-Valentin M, Fenouil T, Bonjour M, et al.
Neuromuscul Disord
. 2024 Jul;
42:5-13.
PMID: 39059057
Granulomatous myositis is a clinical-pathological entity, which has been rarely reported, mostly described in sarcoidosis. Currently, no clear and simple prognostic factor has been identified to predict granulomatous myositis evolution....
5.
Grangeon L, Boulouis G, Capron J, Bala F, Renard D, Raposo N, et al.
Neurology
. 2024 Jun;
103(2):e209548.
PMID: 38900992
Background And Objectives: Cerebral amyloid angiopathy-related inflammation (CAA-RI) and biopsy-positive primary angiitis of the CNS (BP-PACNS) have overlapping clinicoradiologic presentations. It is unknown whether clinical and radiologic features can differentiate...
6.
Desaintjean C, Ahmad K, Traclet J, Gerfaud-Valentin M, Durel C, Glerant J, et al.
Front Med (Lausanne)
. 2024 Apr;
11:1341310.
PMID: 38585151
Introduction: Asthma associated with eosinophilic granulomatosis with polyangiitis (EGPA) is often severe and corticosteroid-dependent, leading to significant morbidity. Mepolizumab and benralizumab are humanized monoclonal antibodies targeting interleukin 5 (IL-5) and...
7.
Groh M, Fenwarth L, Labro M, Boudry A, Fournier E, Wemeau M, et al.
Am J Hematol
. 2024 Apr;
99(6):1108-1118.
PMID: 38563187
We investigated using a custom NGS panel of 149 genes the mutational landscape of 64 consecutive adult patients with tyrosine kinase fusion-negative hypereosinophilia (HE)/hypereosinophilic syndrome (HES) harboring features suggestive of...
8.
Fargeas M, Devouassoux G, Gerfaud-Valentin M
Respir Med Res
. 2023 Dec;
85:101070.
PMID: 38141578
No abstract available.
9.
Jacquot R, Jamilloux Y, Bert A, Gerfaud-Valentin M, Richard-Colmant G, Kodjikian L, et al.
Ocul Immunol Inflamm
. 2023 Nov;
32(8):1655-1666.
PMID: 37948510
Purpose: Determining uveitis etiology is a challenge. It is based primarily on demographic data and the characteristics of eye examination. It is not clear to what extent extraocular physical signs...
10.
Ferracci D, Mathis T, Gavoille A, Gerfaud-Valentin M, Bert A, Hafidi M, et al.
J Clin Med
. 2023 Aug;
12(16).
PMID: 37629330
Purpose: To report the progression of patients diagnosed with birdshot chorioretinopathy (BSCR) initially treated with corticosteroids. Methods: We included 39 BSCR patients that were followed for ≥1 year. We analyzed...